Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2
Kudo, M; Galle, PR; Brandi, G; Kang, YK; Yen, CJ; Finn, RS; Llovet, JM; Assenat, E; Merle, P; Chan, SL; Palmer, DH; Ikeda, M; Yamashita, T; Vogel, A; Huang, YH; Abada, PB; Yoshikawa, R; Shinozaki, K; Wang, CX; Widau, RC; Zhu, AX
Kudo, M (corresponding author), Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, 377-2 Ohno Higashi, Osaka, Osaka 5898511, Japan.; Zhu, AX (corresponding author), Massachusetts Gen Hosp, Canc Ctr, Liver Canc Res, 52 Fruit St, Boston, MA 02115 USA.
JHEP REPORTS, 2021; 3 (2):